Tait R C, Burnett A K, Robertson A G, McNee S, Riyami B M, Carter R, Stevenson R D
Department of Haematology, Royal Infirmary, Glasgow, Scotland.
Int J Radiat Oncol Biol Phys. 1991 Jun;20(6):1219-27. doi: 10.1016/0360-3016(91)90231-r.
Pulmonary function results pre- and post-transplant, to a maximum of 4 years, were analyzed in 98 patients with haematological disorders undergoing allogeneic (N = 53) or autologous bone marrow transplantation (N = 45) between 1982 and 1988. All received similar total body irradiation based regimens ranging from 9.5 Gy as a single fraction to 14.4 Gy fractionated. FEV1/FVC as a measure of airway obstruction showed little deterioration except in patients experiencing graft-versus-host disease in whom statistically significant obstructive ventilatory defects were evident by 6 months post-transplant (p less than 0.01). These defects appeared to be permanent. Restrictive ventilatory defects, as measured by reduction in TLC, and defects in diffusing capacity (DLCO and KCO) were also maximal at 6 months post-transplant (p less than 0.01). Both were related, at least in part, to the presence of GVHD (p less than 0.01) or use of single fraction TBI with absorbed lung dose of 8.0 Gy (p less than 0.05). Fractionated TBI resulted in less marked restricted ventilation and impaired gas exchange, which reverted to normal by 2 years, even when the lung dose was increased from 11.0 Gy to between 12.0 and 13.5 Gy. After exclusion of patients with GVHD (30% allografts) there was no significant difference in pulmonary function abnormalities between autograft and allograft recipients.
对1982年至1988年间接受异体(N = 53)或自体骨髓移植(N = 45)的98例血液系统疾病患者移植前后最长4年的肺功能结果进行了分析。所有患者均接受了类似的全身照射方案,单次照射剂量范围为9.5 Gy至分次照射剂量为14.4 Gy。作为气道阻塞指标的FEV1/FVC除在发生移植物抗宿主病的患者中有所恶化外变化不大,在这些患者中,移植后6个月出现了具有统计学意义的阻塞性通气缺陷(p < 0.01)。这些缺陷似乎是永久性的。以TLC降低衡量的限制性通气缺陷以及弥散功能缺陷(DLCO和KCO)在移植后6个月时也最为明显(p < 0.01)。两者均至少部分与移植物抗宿主病的存在(p < 0.01)或单次照射全身照射且肺部吸收剂量为8.0 Gy有关(p < 0.05)。分次全身照射导致的限制性通气和气体交换受损不太明显,即使肺部剂量从11.0 Gy增加到12.0至13.5 Gy之间,到2年时也恢复正常。排除患有移植物抗宿主病的患者(30%的异体移植)后,自体移植和异体移植受者之间的肺功能异常无显著差异。